ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Rapid generation of combined CMV-specific CD4(+) and CD8(+) T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants
Author(s): Rauser G, Einsele H, Sinzger C, Wernet D, Kuntz G, Assenmacher M, Campbell JDM, Topp MS
Source: BLOOD    Volume: 103    Issue: 9    Pages: 3565-3572    Published: MAY 1 2004  
Times Cited: 66     References: 36     
Abstract: Adoptive transfer of cytomegalovirus (CMV)-specific T cells can restore long-lasting, virus-specific immunity and clear CMV viremia in recipients of allogeneic stem cell transplants if CD4+ and CD8+ CMV-specific T cells are detected in the recipient after transfer. Current protocols for generating virus-specific T cells use live virus, require leukapheresis of the donor, and are time consuming. To circumvent these limitations, a clinical-scale protocol was developed to generate CMV-specific T cells by using autologous cellular and serum components derived from a single 500-mL blood draw. CMV-specific T cells were stimulated simultaneously with CMV-specific major histocompatibility complex class 1 (MHC 1)-restricted peptides and CMV antigen. Activated T cells were isolated with the interferon-gamma (IFN-gamma) secretion assay and expanded for 10 days. In 8 randomly selected, CMV-seropositive donors, 1.34 x 10(8) combined CD4(+) and CD8(+) CMV-specific T cells, on average, were generated, as determined by antigen-triggered IFN-gamma production. CMV-infected fibroblasts were efficiently lysed by the generated T cells, and CMV-specific CD4(+) and CD8(+) T cells expanded if they were stimulated with natural processed antigen. On the other hand, CD4(+) and CD8(+) T cell-mediated alloreactivity of generated CMV-specific T-cell lines was reduced compared with that of the starting population. In conclusion, the culture system developed allowed the rapid generation of allodepleted, highly enriched, combined CD4(+) and CD8(+) CMV-specific T cells under conditions mimicking good manufacturing practice. (C) 2004 by The American Society of Hematology.
Document Type: Article
Language: English
Reprint Address: Topp, MS (reprint author), Univ Tubingen, Med Klin 2, Otfried Muller Str 10, D-72076 Tubingen, Germany
Addresses:
1. Univ Tubingen, Med Klin 2, D-72076 Tubingen, Germany
2. Miltenyi Biotec, Bergisch Gladbach, Germany
Publisher: AMER SOC HEMATOLOGY, 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
Subject Category: Hematology
IDS Number: 822UJ
ISSN: 0006-4971
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo